These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23729329)

  • 21. A new approach to primary prevention of cardiovascular disease.
    Kostis JB
    Am J Med; 2007 Sep; 120(9):746-7. PubMed ID: 17765038
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary prevention for cardiovascular diseases: can statins replace aspirin?
    Abdul Hadi M; Ming LC; Awaisu A
    Med Princ Pract; 2011; 20(6):584. PubMed ID: 21986022
    [No Abstract]   [Full Text] [Related]  

  • 23. Public health. Experts debate polypill: a single pill for global health.
    Reardon S
    Science; 2011 Sep; 333(6051):1813. PubMed ID: 21960602
    [No Abstract]   [Full Text] [Related]  

  • 24. Primary prevention of cardiovascular disease risk factors: review and implications for population-based practice.
    Meininger JC
    Adv Pract Nurs Q; 1997; 3(2):70-9. PubMed ID: 9432456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An appeal for reimbursement for innovative prevention measures in patient cardiovascular education.
    Frohlich ED
    Nat Clin Pract Cardiovasc Med; 2008 Apr; 5(4):175. PubMed ID: 18368009
    [No Abstract]   [Full Text] [Related]  

  • 26. Primordial prevention of cardiovascular disease through applied genetics.
    Williams RR; Hopkins PN; Stephenson S; Wu L; Hunt SC
    Prev Med; 1999 Dec; 29(6 Pt 2):S41-9. PubMed ID: 10641817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Can cardiovascular prevention be modernized?].
    Marrugat J
    Rev Clin Esp (Barc); 2014; 214(5):253-5. PubMed ID: 24655925
    [No Abstract]   [Full Text] [Related]  

  • 28. [Strategies for cardiovascular prevention in women].
    Leuzzi C; Modena MG
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):93S-96S. PubMed ID: 20879491
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk refinement, reclassification, and treatment thresholds in primary prevention of cardiovascular disease: incremental progress but significant gaps remain.
    O'Malley PG; Redberg RF
    Arch Intern Med; 2010 Sep; 170(17):1602-3. PubMed ID: 20876413
    [No Abstract]   [Full Text] [Related]  

  • 30. Are statins effective in high-risk primary prevention?
    Dentali F; Guasti L
    Arch Intern Med; 2010 Dec; 170(22):2042-3; author reply 2043-4. PubMed ID: 21149769
    [No Abstract]   [Full Text] [Related]  

  • 31. Appropriate clinical use of statins: a discussion of the evidence, scope, benefits, and risk.
    Perlmutter D; Golomb B; Sinatra S; Campbell AW
    Altern Ther Health Med; 2013; 19 Suppl 1():14-25. PubMed ID: 23981463
    [No Abstract]   [Full Text] [Related]  

  • 32. The cardiovascular polypill in high-risk patients.
    Lafeber M; Spiering W; Singh K; Guggilla RK; Patil V; Webster R;
    Eur J Prev Cardiol; 2012 Dec; 19(6):1234-42. PubMed ID: 22019908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The polypill and cardiovascular disease.
    Fahey T; Brindle P; Ebrahim S
    BMJ; 2005 May; 330(7499):1035-6. PubMed ID: 15879368
    [No Abstract]   [Full Text] [Related]  

  • 34. The prevention of cardiovascular disease: have we really made progress?
    Pearson TA
    Health Aff (Millwood); 2007; 26(1):49-60. PubMed ID: 17211013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary prevention of cardiovascular disease and other chronic noncommunicable diseases in the centre of attention of the United Nations: special importance of a prudent diet.
    Szostak WB; Cybulska B; Kłosiewicz-Latoszek L; Szostak-Węgierek D
    Kardiol Pol; 2013; 71(4):321-4. PubMed ID: 23788336
    [No Abstract]   [Full Text] [Related]  

  • 36. [Position paper on the primary prevention of cardiovascular diseases. Current position of the 25.3.2003 Statement of the Board of the German Society of Cardiology--heart and circulatory research work commissioned by for the board by Project Group on Prevention].
    Gohlke H; Kübler W; Mathes P; Meinertz T; Schuler G; Gysan DB; Sauer G;
    Z Kardiol; 2005; 94 Suppl 3():III/113-5. PubMed ID: 16258788
    [No Abstract]   [Full Text] [Related]  

  • 37. Populations and polypills: if yes, then how?
    Cooper RS; Layden J
    J Epidemiol Community Health; 2013 Nov; 67(11):903-4. PubMed ID: 23833188
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of cardiovascular risk factors in the first place.
    Labarthe DR
    Prev Med; 1999 Dec; 29(6 Pt 2):S72-8. PubMed ID: 10641821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing Heart disease: who needs to be concerned and what to do.
    Sidani M; Ziegler C
    Prim Care; 2008 Dec; 35(4):589-607. PubMed ID: 18928820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time for results: a better way to reduce cardiovascular risk.
    Mola A; Lloyd M
    Adv Nurse Pract; 2002 Apr; 10(4):34-41; quiz 42-3. PubMed ID: 12418348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.